|
Volumn 49, Issue 4, 2001, Pages 387-396
|
Orphan drugs: Some legal, ethical and economics aspects;Médicaments orphelins: Quelques aspects juridiques, éthiques et économiques
|
Author keywords
Orphan drugs; Rare diseases; Regulation
|
Indexed keywords
ORPHAN DRUG;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MANUFACTURE;
ECONOMIC ASPECT;
ETHICS;
EUROPE;
FINANCIAL MANAGEMENT;
HUMAN;
REVIEW;
DRUG AND NARCOTIC CONTROL;
DRUG COSTS;
DRUG INDUSTRY;
DRUG INFORMATION SERVICES;
ETHICS, MEDICAL;
EUROPE;
FRANCE;
HEALTH POLICY;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
MARKETING OF HEALTH SERVICES;
ORPHAN DRUG PRODUCTION;
PREVALENCE;
PUBLIC HEALTH;
REGISTRIES;
RESEARCH SUPPORT;
UNITED STATES;
|
EID: 17044462003
PISSN: 03987620
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (5)
|
References (19)
|